Marisa
Crespo Leiro
King's College Hospital
Londres, Reino UnidoPublications in collaboration with researchers from King's College Hospital (11)
2024
2023
-
Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes – from the ESC-HFA EORP Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 25, Núm. 9, pp. 1571-1583
-
Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry
European Heart Journal, Vol. 44, Núm. 17, pp. 1526-1529
-
Prevalence, characteristics and prognostic impact of aortic valve disease in patients with heart failure and reduced, mildly reduced, and preserved ejection fraction: An analysis of the ESC Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 25, Núm. 7, pp. 1049-1060
-
Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: An analysis from the ESC-HFA Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 25, Núm. 7, pp. 1061-1071
2022
-
A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction – insights from the ESC-HFA EORP Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 24, Núm. 2, pp. 335-350
2020
-
Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 22, Núm. 8, pp. 1424-1437
-
Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology - Heart Failure Association EURObservational Research Programme Heart Failure Long-Term Registry
ESC Heart Failure, Vol. 7, Núm. 5, pp. 2098-2112
-
Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 22, Núm. 8, pp. 1378-1389
2019
-
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world
European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1383-1397
2016
-
Heart Failure Association of the European Society of Cardiology heart failure nurse curriculum
European Journal of Heart Failure, Vol. 18, Núm. 7, pp. 736-743